期刊文献+

N-烷基-1,10-菲咯啉2-甲胺La(Ⅲ)配合物的合成及抗癌活性 被引量:5

Synthesis and Antitumor Activity of Lanthanum(Ⅲ) Complexes to N-Alkyl-1,10-phenanthroline-2-methanamine
下载PDF
导出
摘要 合成和表征了甲基、乙基、丙基、丁基和苄基N-取代1,10-菲咯啉2-甲胺衍生配体及其镧(Ⅲ)配合物.研究了配合物对HL60人白血病、PC-3MIE8人前列腺癌、BGC-823人胃癌、MDA-MB-435人乳腺癌、Bel-7402人肝癌、Hela人宫颈癌共6种瘤株的体外抗肿瘤活性及其与DNA的作用方式.结果表明,该系列化合物对实验的6种瘤株均具有不同程度的生长抑制作用,其中配合物L5LaL5对MDA-MB-435人乳腺癌和Bel-7402人肝癌的抑制效果较好,对Bel-7402人肝癌和Hela人宫颈癌的抑制效果优于顺铂.其作用机理可能是配合物以部分插入方式同时伴随共价和静电与DNA发生作用,影响其基因调控与表达,进而抑制肿瘤细胞的生长,最终导致癌细胞凋亡. Five lathanum( Ⅲ ) complexes containing 1,10-phenanthroline units were synthesized and characterized by elemental analyses, ^1 H HMR and IR spectra. All complexes were assayed for antitumor activity in vitro against HL-60(human leukocytoma) cells, PC-3MIE8(human prostate carcinoma) cells, BGC-823(human stomach carcinoma) cells, MDA-MB-435 (human galactophore carcinoma) cells, Bel-7402 (human liver carcinoma) cells and Hela( human cervix carcinoma) cells. The results show that the complexes exhibit good growth inhibition against different cell lines in general. DNA binding studies indicate that the complexes possibly interact with ctDNA by part intercalative, covalent binding and electrostatic effection.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2006年第10期1800-1804,共5页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:29971018) 天津市自然科学基金(批准号:023605811)资助.
关键词 邻菲咯啉 镧(Ⅲ)配合物 抗癌活性 DNA Phenanthroline La( Ⅲ ) complex Antitumor activity DNA
  • 相关文献

参考文献21

  • 1Rosenberg B.. Cancer[J], 1985, 55:2303-2310
  • 2Bogdanov A. A. J. , Martin C. , Bogdanova A. V. et al.. Bioconjugate Chem. [J] , 1996, 7:144-149
  • 3Meyn R. E. , Stephens L. C. , Hunter N. R. et al.. Int. J. Cancer[J] , 1995, 60:725-729
  • 4Francisco J. R. , Oldrich V. , Adoracio'n G. Q. et al.. J. Med. Chem. [J], 2006, 49:2640-2651
  • 5Jaroslav M. , Marie V. , Viktor B. et al.. Biochemical and Biophysical Research Communications[J], 2005, 332:1034-1041
  • 6Petra H. , Michael A. J. , Wilfried K. et al.. Biochemical Pharmacology[J] , 2006, 71:426-440
  • 7Li F. H. , Zhao G. H. , Wu H. X. et al.. Journal of Inorganic Biochemistry[J] , 2006, 100:36-43
  • 8Upal K. M. , Malaya G. , Subhas S. K. et al.. Bioorganic & Medicinal Chemistry[J], 2005, 13:5766-5773
  • 9Mlochowski J. , Sliwa W. , Skrowaczewska Z.. Pol. 76345 (C1 C07D) [P] , 1975
  • 10Barton J. K., Goldberg J. M., Kumar C. V. et al.. J. Am. Chem. Soc. [J], 1986, 108:2081-2090

二级参考文献55

  • 1李军智,江敏,薛玉川,甄永苏.抗癌抗生素C1027与单克隆抗体Fab片段偶联物的抗肝癌作用[J].药学学报,1993,28(4):260-265. 被引量:8
  • 2阎蕴力,郑力芬,王美华,杨天祝,马常生.威猛(Vm-26)对Hela细胞染色体形成的影响[J].癌变.畸变.突变,1996,8(3):161-164. 被引量:3
  • 3Sinha BK. Topoisomerase inhibitors-a review of their therapeutic potential in cancer[J]. Drugs, 1995,49(1): 11-19.
  • 4Fortune JM, Osheroff N. Merbarone inhibits the catalytic activity othuman topoisomerase Ⅱ α by blocking DNA cleavage[J]. J Biol Chem, 1998, 273(28) : 17 643 - 17 650.
  • 5Nagata T, Higashigawa M, Shimono Y, et al. Aclarubicine inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 mutine leukemia cens[J]. J Exp Clin Cancer Res,1998, 17(4) : 435 - 443.
  • 6Grue P, Grabert A, Sehested M, et al. Essential mitotic function of DNA topoisomerase Ⅱ α are not adopted by topoisomerase Ⅱ β in human H69 cells[J]. J Biol Chem, 1998, 273(50) : 33 660 -33 666.
  • 7Warburton PE, Eamshaw WC. Untangling the role of DNA topoisomerase Ⅱ in mitotic chromosome structure and function[J]. Bio Essays, 1995, 19(2) : 97 - 99.
  • 8Charron M, Hancock R. DNA topoisomerase Ⅱ is required for formation of mitotic chromosomes in Chinese hamster ovary cells:Studies using the inhibitor 4'-Demethylepipodophyllotoxin 9-(4,60-Thenylidem-β-d-glucopyranoside)Biochem,1990,29(41): 531- 9 537.
  • 9Chen M, Beck W. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase Ⅱ inhibitors Merbarone and VM-26[J]. Cancer Res, 1995, 55(7) : 1 509- 1 516.
  • 10Gorbsky GJ. Cell cycle progression and chromosome segregation in mammalian cell cultured in the presence of the tpoisomerase Ⅱ inhibitors ICRF-187[( + ) - 1, 2- his(3, 5-dioxopiperazinyl-l-yl)propane; ADR-529] and ICRF-159 (Razoxane)[J]. Career Res,1994, 54(4) : 1 042 - 1 048.

共引文献24

同被引文献78

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部